Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer
Status:
Withdrawn
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
This is a parallel-track, randomized study will observe whether intravenous ascorbic acid
reduces the reported fatigue in women receiving adjuvant or neo-adjuvant chemotherapy for
early stage breast cancer.